[HTML][HTML] Late SV40 factor: a key mediator of Notch signaling in human hepatocarcinogenesis

RH Fan, J Li, N Wu, PS Chen - World journal of gastroenterology …, 2011 - ncbi.nlm.nih.gov
AIM: To investigate the relationship between late SV40 factor (LSF) and Notch signaling in
the development and progress of hepatocellular carcinoma (HCC). METHODS: Liver cancer …

Cooperation of deregulated Notch signaling and Ras pathway in human hepatocarcinogenesis

R Fan, P Chen, D Zhao, J Tong, J Li, F Liu - Journal of molecular histology, 2011 - Springer
Abstract Aberrant Notch signaling and Ras pathway had been highlighted a potential role for
in human cancers. Yet, relatively little was known about the roles of wild type Notch …

Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma

BK Yoo, L Emdad, R Gredler, C Fuller… - Proceedings of the …, 2010 - National Acad Sciences
Hepatocellular carcinoma (HCC) is a highly aggressive cancer with no currently available
effective treatment. Understanding of the molecular mechanism of HCC development and …

Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9)

PK Santhekadur, R Gredler, D Chen, A Siddiq… - Journal of Biological …, 2012 - ASBMB
The transcription factor late SV40 factor (LSF) is overexpressed in human hepatocellular
carcinoma (HCC) fostering a highly aggressive and metastatic phenotype. Angiogenesis is …

[PDF][PDF] Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma

SO Lim, YM Park, HS Kim, X Quan, JE Yoo… - …, 2011 - Wiley Online Library
The tumor suppressor p53 is a key prognostic factor in hepatocellular carcinoma (HCC), yet
only 35% of grade III tumors exhibit mutation of p53. Several other pathways have been …

c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF

BK Yoo, R Gredler, D Chen, PK Santhekadur… - Journal of …, 2011 - Elsevier
BACKGROUND & AIMS: Understanding the molecular pathogenesis of hepatocellular
carcinoma (HCC) would facilitate development of targeted and effective therapies for this …

[HTML][HTML] Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model

D Rajasekaran, A Siddiq, JLS Willoughby, JM Biagi… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a lethal malignancy with high mortality and poor
prognosis. Oncogenic transcription factor Late SV40 Factor (LSF) plays an important role in …

Notch3 intracellular domain accumulates in HepG2 cell line

C Giovannini, M Lacchini, L Gramantieri… - Anticancer …, 2006 - ar.iiarjournals.org
Background: By mediating local cell-cell interactions, the Notch signaling pathway seems to
control a variety of processes from cell fate decisions during development, to stem cell …

[HTML][HTML] Transcription factor LSF (TFCP2) inhibits melanoma growth

Y Goto, I Yajima, M Kumasaka, N Ohgami, A Tanaka… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Abstract Late SV40 factor 3 (LSF), a transcription factor, contributes to human hepatocellular
carcinoma (HCC). However, decreased expression level of LSF in skin melanoma …

Oncogenic role of the Notch pathway in primary liver cancer (Review) Corrigendum in/10.3892/ol. 2016.5145

J Lu, Y Xia, K Chen, Y Zheng, J Wang… - Oncology …, 2016 - spandidos-publications.com
Primary liver cancer, which includes hepatocellular carcinoma (HCC), intrahepatic
cholangiocarcinoma (ICC) and fibrolamellar HCC, is one of the most common malignancies …